Kedaara Capital and TA Associates are in talks to acquire a significant minority stake in Sagent Pharma, valued at $500-600 ...

The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary ...

The 48 innovative drugs cover nearly 20 therapeutic areas, including oncology, neurological disorders and anti-infective ...

China approved 48 first-in-class innovative drugs in 2024, covering nearly 20 therapeutic areas, including oncology, neurological disorders, endocrine diseases and anti-infective medicines, according ...

Creative Diagnostics has announced its comprehensive Drug Discovery Services for antiviral therapeutic development. NEW YORK, NY, UNITED ST ...

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to ... sole synthetic polymer and sepsis drug candidate in development.

Recce’s anti-infective pipeline includes three patented ... Development Pipeline as the sole synthetic polymer and sepsis drug candidate in development. Recce wholly owns its automated ...

Category 3: Auto-immune, anti-cancer, anti-diabetic, anti-infective, cardiovascular and psychotropic drugs, as well as anti-retroviral drugs (including HIV-treating medicines). The government's ...

Alkem Laboratories launches generic empagliflozin in India as Empanorm, offering affordable treatment for diabetes and related conditions.

The Grand Island plant produces drugs in four therapeutic classes: anti-infective drugs, anesthetics, critical care products and oncology products. Its oncology products portfolio is about to move ...